Genetic and epigenetic programming of T helper (Th) cell subsets during their polarization from naive Th cells establishes long-lived memory Th cells that stably maintain their lineage signatures. However, whether memory Th cells can be redifferentiated into another Th lineage is unclear. In this study, we show that Ag-specific memory Th cells were redifferentiated into Foxp3 + T cells by TGF-β when stimulated in the presence of all-trans retinoic acid and rapamycin. The "converted" Foxp3 + T cells that were derived from Th2 memory cells downregulated GATA-3 and IRF4 and produced little IL-4, IL-5, and IL-13. Instead, the converted Foxp3 + T cells suppressed the proliferation and cytokine production of Th2 memory cells. More importantly, the converted Foxp3 + T cells efficiently accumulated in the airways and significantly suppressed Th2 memory cell-mediated airway hyperreactivity, eosinophilia, and allergen-specific IgE production. Our findings reveal the plasticity of Th2 memory cells and provide a strategy for adoptive immunotherapy for the treatment of allergic diseases.
Genetic and epigenetic programming of T helper (Th) cell subsets during their polarization from naive Th cells establishes long-lived memory Th cells that stably maintain their lineage signatures. However, whether memory Th cells can be redifferentiated into another Th lineage is unclear. In this study, we show that Ag-specific memory Th cells were redifferentiated into Foxp3 + T cells by TGF-β when stimulated in the presence of all-trans retinoic acid and rapamycin. The "converted" Foxp3 + T cells that were derived from Th2 memory cells downregulated GATA-3 and IRF4 and produced little IL-4, IL-5, and IL-13. Instead, the converted Foxp3 + T cells suppressed the proliferation and cytokine production of Th2 memory cells. More importantly, the converted Foxp3 + T cells efficiently accumulated in the airways and significantly suppressed Th2 memory cell-mediated airway hyperreactivity, eosinophilia, and allergen-specific IgE production. Our findings reveal the plasticity of Th2 memory cells and provide a strategy for adoptive immunotherapy for the treatment of allergic diseases.
all-trans retinoic acid | immune tolerance | immunotherapy | plasticity | rapamycin U pon antigen exposure, naive T helper (Th) cells are activated and then undergo several divisions to differentiate into specialized effector T cells, including Th1, Th2, and Th17, each of which has its own characteristic cytokine expression pattern (1) . Each Th subset maintains its cytokine expression and represses opposing Th cytokine expression by coordinating the regulation of master transcription factors. Additionally, chromatin remodeling and epigenetic modifications, such as DNA methylation and histone acetylation, of specific cytokine gene loci support the stability of Th cell fates. These epigenetic modifications are inherited by daughter cells as the cell divides, and the modifications also persist in memory cells, thus accounting for the rigid nature of Th lineages (2, 3) .
Recently, however, the classical notion that Th cell lineage commitment is irreversible has been challenged (4) . For example, it has been reported that Foxp3 + regulatory T cells (Tregs) can be converted into Th17 cells under Th17-polarizing conditions, and Th17 cells become IFN-γ-producing cells in the presence of IL-12 (5-7). In addition, Th1 and Th2 memory cells have been reported to be interconvertible under conditions that promote the opposite Th lineage (8) . However, whether Th1 and Th2 memory cells can be redifferentiated into Foxp3 + Tregs has not been explored. The clinical potency of Treg-based adoptive immunotherapy has been proven in several disease settings, including transplantation and the treatment of autoimmune and allergic diseases (9) (10) (11) . With a few successful applications of Tregs in animal studies, at least two phase I clinical trials using Tregs are now being conducted in hematopoietic stem cell transplantation and type 1 diabetes (12) . Until now, one of the major obstacles to the clinical application of Treg therapy has been the scarcity of Tregs in human peripheral blood (13) . To overcome this problem, TGF-β-mediated induction of Tregs from abundant naive precursors has been used (14) . In addition, all-trans retinoic acid (ATRA) has been reported to enhance TGF-β-mediated Foxp3 induction in naive Th cells either by a direct effect on naive Th cells or by an indirect effect on cytokine production of memory Th cells (15) (16) (17) . Furthermore, rapamycin, a mammalian target of rapamycin (mTOR) inhibitor, can enrich Foxp3 + Tregs through Foxp3-mediated induction of Pim 2 (18). However, whether the TGF-β-mediated Foxp3 induction in effector/memory Th cells can be enhanced by ATRA and rapamycin remains to be elucidated.
Here, we show that TGF-β-mediated Foxp3 expression in Agspecific Th2 memory cells can be enhanced by ATRA and can be further enhanced by rapamycin. The resultant Th2 memory-derived Foxp3 + cells can efficiently modulate Th2 memory-induced airway hyperreactivity (AHR) and eosinophilia. These results demonstrate that, with the proper manipulation, Ag-specific Th2 memory cells can be induced to express Foxp3, providing guidance for developing an effective and safe Treg-based immunotherapy.
Results

Ag-Specific Th2 Memory Cells Do Not Express Foxp3 in Response to
TGF-β Plus All-Trans Retinoic Acid. In naive Th cells, TGF-β induces Foxp3 expression, which is further synergized with ATRA (14, 15, 17) . To determine whether Ag-specific Th2 memory cells can also express Foxp3 in response to these factors, we generated ovalbumin (OVA)-specific Foxp3 − Th2 memory cells by using naive OVAspecific CD4 +
Foxp3
− T cells isolated from DO11.10-RAG2 −/− mice (19) . Purified naive Th cells were stimulated with irradiated splenocytes plus the OVA 323-339 peptides under Th2-polarizing conditions for 3 days. These activated T cells were adoptively transferred into syngeneic BALB/c mice to induce them to become memory T cells (20 (Fig.  S1A) . Functionally, the former promptly produced IL-4 but not IFN-γ upon restimulation with their cognate peptide ex vivo (Fig. S1B) . Taken together, these results demonstrate that, in the context of both phenotype and function, Th2-polarized donor T cells in the recipient established genuine Ag-specific Th2 memory cells.
When we purified the Th2 memory cells and stimulated them with spleen dendritic cells (DCs) and OVA 323-339 peptides in the presence of TGF-β and/or ATRA, little Foxp3 expression was observed (Fig. 1A) . We also obtained OVA-specific Th1 memory cells by similar methods (Fig. S1 C and D) and found a similar inefficient Foxp3 expression in response to TGF-β and ATRA (Fig. S1E) . Therefore, Ag-specific Th2 memory cells as well as Th1 memory cells are resistant to Foxp3 induction in response to TGF-β and ATRA.
Rapamycin and ATRA Synergistically Increase TGF-β-Mediated Foxp3 Induction in Ag-Specific Th2 Memory Cells in the Presence of Effector Cytokine Neutralization. Th1 and Th2 effector cytokines have been shown to inhibit Treg differentiation as well as Th17 differentiation (1, 21, 22) . In addition, mTOR signaling attenuates TGF-β-mediated Foxp3-inducing signals (23) (24) (25) . Therefore, we hypothesized that the resistance of Ag-specific memory Th cells against TGF-β-mediated Foxp3 induction could be due to inefficient TGF-β signaling mediated by effector cytokines and/or the activated mTOR pathway. To test this hypothesis, we added neutralizing anti-IL-4 and anti-IFN-γ Abs to the culture of Th2 memory cells. Notably, a considerable population of Foxp3 + cells was induced by TGF-β, anti-IL-4, and anti-IFN-γ, and the Foxp3 + cells were significantly increased by ATRA (Fig. 1A) . Interestingly, further addition of mTOR inhibitor rapamycin greatly enhanced TGF-β-mediated Foxp3 induction in Th2 memory cells, in which over 60% were Foxp3 + (Fig. 1A) . Similarly, Foxp3 + cells were substantially induced by treating Th1 memory cells with a combination of TGF-β, anti-IFN-γ Ab, ATRA, and rapamycin ( Fig. S1E ). We observed a similar enhancement of Foxp3 expression by ATRA and rapamycin in an antigen presenting cell (APC)-free system with little effect on cell viability, demonstrating the T-cell intrinsic effects of these reagents ( Fig. 1 B and C and Fig. S2) .
Notably, addition of ATRA or rapamycin 3 days after restimulation failed to increase the Foxp3 + population ( Fig. S3 A-C). Therefore, both signals are required during the early phase of T cell receptor (TCR) restimulation to induce optimal expression of Foxp3 in Th2 memory cells.
+ T Cells Converted from Th2 Memory Cells Do Not Express GATA-3 and Th2 Cytokines. We next compared gene expression profiles among naive Th cells, Th2 memory cells, and Th2 memory-derived Tregs (we will refer to the Th2 memory cells restimulated in the presence of TGF-β, anti-IL-4, anti-IFN-γ, ATRA, and rapamycin as Th2 memory-derived Tregs because we discovered that they are regulatory T cells, as described below). Purified Th2 memory cells expressed high levels of Th2 signature genes, including Gata3, Irf4, Il4, Il5, Il13, and Ccr4, at the transcript level. In contrast, Th2 memory-derived Tregs profoundly downregulated all these Th2 signature genes except Ccr4 with high expression of Foxp3 (Fig. S4 ).
To confirm these findings at the protein level, we costained the cells with Foxp3 and GATA-3 or IL-4 or IL-13. Consistent with a previous report (26) , TGF-β down-regulated GATA-3 expression in Th2 memory cells. Interestingly, TGF-β plus anti-IL-4 almost completely abrogated GATA-3 expression in Th2 memory cells (Fig. S5) . Similarly, TGF-β plus anti-IFN-γ almost completely suppressed T-bet expression in Th1 memory cells (Fig. S1E ). In addition, TGF-β and anti-IL-4 significantly decreased the proportion of either IL-4-or IL-13-producing cells within the Th2 memory cell population (Fig. S5) . As a result, Th2 memory-derived Tregs contained few GATA-3-expressing and IL-4-or IL-13-producing cells ( Fig. 2 A and B) . This observation was further confirmed by measuring levels of IL-4, IL-5, and IL-13 from the Tcell culture supernatant after restimulation (Fig. 2C ).
Recent studies have identified IL-9-producing cells whose polarization is mediated by TGF-β and IL-4 signals (27, 28) . Interestingly, a considerable proportion of Th2 memory cells produced IL-9 when restimulated in the presence of TGF-β. In contrast, Th2 memory-derived Tregs produced little IL-9, probably due to the complete blockade of the IL-4 signal (Fig. 2D) .
We then determined whether Th2 memory-derived Tregs bear Th2-type integrin and homing receptors. As expected, naive Th cells expressed the lymph node-homing receptor CCR7 but not the lung-homing receptor CCR4 (Fig. S6A) . Conversely, Th2 memory-derived Tregs down-regulated CCR7 and highly expressed CCR4 (Fig. S6A) . Also, Th2 memory-derived Tregs highly expressed CD103 (αE), which may contribute to their retention and/or accumulation in the lung tissue ( Fig. S6 A and B) (29) . These observations led us to examine the lung-homing capacity of the Th2 memory-derived Tregs. Two days after transfer into congenic mice, both Th2 memory-derived Tregs and naive Th cells were detectable in the spleen. In contrast, only Th2 memoryderived Tregs were detected in the lung, which correlated with their high expression of CCR4; however, the proportion of Foxp3-expressing cells within this lung Treg population was lower than that of the spleen population (Fig. S6C) . Notably, the Foxp3 + proportion of Th2 memory-derived Tregs in the lung was significantly increased after intranasal (i.n.) administration of their cognate antigen (Fig. S6D) . Therefore, the Th2 memory-derived Tregs maintained the lung-homing capacity of Th2 memory cells even with diminished Th2 gene profiles. + cells expressed slightly reduced levels of CD25, CD39, GITR, PD-1, and ICOS. Interestingly, however, Th2 memory-derived Foxp3 + cells highly expressed FR4, a recently discovered Treg-specific surface marker (30), whereas reactivated Th2 memory cells did not (Fig. 3A) . Therefore, the Foxp3 + T cells derived from Th2 memory cells are phenotypically regulatory T cells.
Next, we analyzed the ability of Th2 memory-derived Tregs to suppress the activity of Th2 memory responder cells. As shown in Fig. 3B , no more than 20% of Th2 memory-derived Tregs divided more than three times, whereas over 90% of Th2 memory cells did. Similarly, Th2 memory-derived Tregs produced little IL-4, IL-5, and IL-13, whereas Th2 memory cells produced a significant amount of these cytokines (Fig. 3C ). In addition, Th2 memoryderived Tregs actively suppressed proliferation and cytokine production of Th2 memory cells in a Treg-to-T effector ratio-dependent manner (Fig. 3 B and C) . Also, the suppressive potency of Th2 memory-derived Tregs (80% Foxp3 + ) was two times higher than naive-induced Tregs (90% Foxp3 + ) (Fig. S7) . Moreover, Th2 memory-derived Tregs stably expressed Foxp3 and produced few Th2 cytokines after restimulation under Th2-polarizing conditions (Fig. S8A) . It is noteworthy that half of the Foxp3 + cells reexpressed GATA-3 under these conditions. More importantly, they also retained suppressive activity against Th2 memory cells, although their potency was slightly reduced (Fig. S8 B and C) . Therefore, Th2 memory-derived Foxp3 + cells are bona fide regulatory T cells with potent and stable suppressive activity.
Ag-Specific Th2 Memory-Derived Regulatory T Cells Ameliorate Th2 Memory-Mediated Airway Hyperreactivity and Eosinophilic Inflammation. Finally, we determined whether the Ag-specific Th2 memory-derived Tregs could suppress Th2 memory-mediated inflammation in vivo. To this end, we adoptively transferred Th2 memory-derived Tregs into Th2 memory-bearing recipients 1 day before i.n. administration of allergen. When we analyzed the mice after airway allergen challenge, Th2 memory-derived Tregs significantly suppressed Th2 memory-mediated AHR and eosinophilia in bronchioalveolar lavage fluid (BALF) (Fig. 4 A and B) . The level of OVA-specific IgE in sera was also greatly decreased by Th2 memory-derived Tregs (Fig. 4C) .
As depicted in Fig. 4D , IL-4-, IL-5-, and IL-13-producing OVA-specific CD4 + T cells in the draining mediastinal lymph node (MdLN) were significantly decreased by Th2 memory-derived Tregs. More importantly, more than 70% of the transferred 
clonotypic T cells were Foxp3
+ in BALF and the lung, indicating efficient homing of the Th2 memory-derived Tregs to the site of Th2-mediated inflammation (Fig. 4E) . Notably, a majority of the OVA-specific Foxp3 + cells coexpressed GATA-3, especially in BALF, with little expression of Th2-type cytokines (Fig. 4 D and  E) , which agrees well with our in vitro observation under Th2-skewing conditions (Fig. S8) . Consistent with their efficient homing to the inflamed airway, OVA-specific Foxp3 + cells in BALF expressed CCR4 and down-regulated CCR7 (Fig. 4F) .
The suppression of Th2 memory cells by Th2 memory-derived Tregs was not due to competition for Ag-bearing APCs, considering that an equal number of naive OVA-specific Th cells did not ameliorate the diseases (Fig. S9 A-C) . Moreover, this suppression was Ag-specific because the OVA-specific Th2 memoryderived Tregs did not affect the AHR response mediated by the unrelated antigen KLH (Fig. S10 A and B) .
We then compared the suppressive potency of Th2 memoryderived Tregs and naturally occurring Tregs (nTregs). To this end, we transferred 1.0 × 10 6 nTregs (>70% OVA-specific, >95% Foxp3 + ) isolated from DO11.10 mice or 7.0 × 10 5 OVA-specific Th2 memory-derived Tregs (>99% OVA-specific, >90% Foxp3 + ) into syngeneic mice. When we induced allergic airway inflammation in the recipient mice, we observed that Th2 memoryderived Tregs were at least as potent as nTregs in suppressing Th2 memory-mediated AHR, eosinophilia, and IgE production (Fig. 4  G-I) . Compared with nTregs, Th2 memory-derived Tregs homed more preferentially to the airway than to the MdLN (Fig. 4J) .
We also addressed whether Th2 memory-derived Tregs could suppress a more robust Th2 response in vivo. To this aim, we first intranasally challenged Th2 memory cell-bearing mice to initiate airway inflammation and then transferred Th2 memory-derived Tregs, as depicted in Fig. S9D . Even in this experimental setting, Th2 memory-derived Tregs efficiently suppressed AHR and allergenspecific IgE production (Fig. 4 G and I) . However, airway eosinophilia was unaffected (Fig. 4H) . Again, a significant proportion of OVA-specific Foxp3 + T cells were detected in the airway (Fig. 4J) . Collectively, these results demonstrate that Th2 memory-derived Tregs stably express Foxp3 upon adoptive transfer; moreover, they efficiently home to the airway to suppress the ongoing airway inflammation that is mediated by Th2 memory cells. Discussion Memory Th cells, especially Th2 memory cells, have been shown to gradually increase in allergic patients with the progression of diseases (31, 32) . It has been unclear, however, whether memory Th cells can become Foxp3 + cells. Compared with naive Th cells, memory Th cells are known to be resistant to TGF-β-mediated expression of Foxp3 (33) . However, after transfer into lymphopenic mice, a preferential conversion of memory Th cells to Tregs compared with that of naive Th cells has been demonstrated (34) . Additionally, human Foxp3 + Tregs are reported to be derived from memory Th cells, especially in elderly people, and human skin-derived memory Th cells can be converted into Foxp3 + Tregs with a suitable manipulation (35, 36) . Our data show that neutralization of IL-4 and IFN-γ is required for TGF-β-mediated Foxp3 induction in Ag-specific memory Th cells. These observations are well supported by several recent studies showing that the TGF-β signal, in the presence of other cytokines, fails to induce Foxp3 expression even in naive Th cells (4, 21, 22) . However, blockade of IL-4 and IFN-γ in combination with TGF-β was not sufficient to induce Foxp3 expression in memory Th cells, even with a great reduction of GATA-3 and T-bet, indicating the existence of additional molecular machinery that mediates resistance to TGF-β-mediated Foxp3 expression.
ATRA synergizes with TGF-β to induce the differentiation of Foxp3 + cells from naive Th cells by enhancing TGF-β-mediated Smad3 signaling (37) , and it inhibits the production of such cytokines as IL-4, IFN-γ, and IL-21 by memory Th cells (16) . Our study demonstrates that the addition of ATRA increases Foxp3 expression in memory Th cells in the presence of neutralizing antibodies against IL-4 and IFN-γ. Therefore, in addition to its role in suppressing the production of cytokines, the ATRA signal also makes memory T cells more susceptible to the TGF-β signal.
Rapamycin has been extensively studied in translational research for its capacity to induce tolerance. Tolerance induction by rapamycin is, at least in part, mediated by its role in the selective expansion of the Tregs (38) . Also, rapamycin-conditioned DCs can enrich Tregs (39) . In addition, the mTOR signaling pathway negatively regulates de novo generation of Tregs (23, 24) . Moreover, recent studies have revealed a critical role of mTOR in the generation of memory T cells as well as in the differentiation of effector T cells (25, 40) . These observations overall led us to hypothesize that active mTOR signaling in memory Th cells is a critical factor for maintaining the resistance of memory Th cells to Foxp3 induction by TGF-β signaling. Indeed, we observed that addition of rapamycin into the culture greatly increased the proportion of Foxp3 + cells in memory Th cells. Kinetic analysis showed that rapamycin acted during the early phase after TCR restimulation, suggesting that it was not the result of selective expansion of induced Foxp3 + cells. However, neutralization of IL-4 and IFN-γ was necessary for rapamycin-mediated enhancement of Foxp3 induction in memory Th cells. Therefore, effector cytokines and mTOR work synergistically to inhibit Foxp3 expression in memory Th cells.
Although Th2 memory cells produced IL-4 but not IFN-γ at an early time point after restimulation, neutralization of IFN-γ was required for optimal induction of Foxp3 + cells in Th2-polarized memory cells. It is likely that some of Th2 memory cells started to produce IFN-γ after 4-5 days of restimulation as recently suggested (41) .
Recent studies have elegantly shown that Foxp3 + T cells expressing T-bet, IRF4, or STAT3 specifically suppress the Th1, Th2, or Th17 response in vivo, respectively (42) (43) (44) . The Th lineagespecific inhibition by each Foxp3 + Treg subset is, at least in part, mediated by their efficient homing to the site of inflammation. Importantly, most of the transferred Th2 memory-derived Tregs in the present study became Foxp3 + GATA-3 + cells upon the triggering of Th2-type airway inflammation. Moreover, the Th2 memory-derived Foxp3 + cells in the inflamed airway maintained CCR4 expression. We propose that Th2 memory-derived Tregs expressing CCR4 efficiently home to the airway and re-express GATA-3 under the Th2-rich environment, which maintains CCR4 expression and facilitates efficient suppression against pathogenic Th2 cells as IRF-4-expressing Tregs (43). Interestingly, the expression level of GATA-3 in Th2 memory-derived Tregs was lower than that in Th2 memory cells, which is similar to the lower expression of T-bet in T-bet + Tregs compared with that in Th1 effector cells (42) . These results suggest that low expression of GATA-3 in Th2 memory-derived Tregs was responsible for their efficient homing to the inflamed airway without redifferentiation into Th2 effector cells. The exact mechanism of GATA-3 re-expression in vivo and its function in the suppression of inflammation in our model need to be elucidated in the future.
It has recently been demonstrated that Tregs down-regulate Foxp3 expression under inflammatory conditions (45, 46) . Although we showed that Th2 memory-derived Tregs stably maintain Foxp3 expression under a Th2-skewing environment both in vitro and in vivo, it is also important to monitor the stability of Foxp3 expression in these cells in the long term. In addition, we support the notion that Treg-mediated adoptive immunotherapy should be used to maintain remission in inflammatory diseases (13) , not only because it is more difficult to inhibit effector function of activated T cells than to inhibit activation of resting T cells, but also because the stability of Foxp3 expression in Tregs could be diminished under strong inflammatory conditions.
Materials and Methods
Mice. Six-to 8-week-old female BALB/c mice were purchased from Charles River Laboratories. DO11.10-RAG2 −/− mice were purchased from Taconics.
Thy1.1 + BALB/c was a kind gift from Charles D. Surh (Scripps Institute). All of the animals were bred and maintained in the animal facility at Seoul National University under specific pathogen-free conditions, and all animal procedures were approved by the Institutional Animal Care and Use Committee at Seoul National University.
Generation and Isolation of Ag-Specific Memory Th Cells. CD4 + T cells were purified from pooled spleen and mesenteric lymph nodes of DO11.10-RAG2 −/− mice via positive selection with CD4 MACS beads and cultured with OVA 323-339 peptides (1 μg/mL) (Peptron) and irradiated (3000 cGy) splenocytes from BALB/c mice. For Th1 polarization, the cells were cultured in the presence of 4 ng/mL IL-12 (eBioscience) and 10 μg/mL anti-IL-4 Ab (clone HB188, ATCC), and for Th2 polarization, the cells were cultured with 10 ng/ mL IL-4 (eBioscience) and 10 μg/mL anti-IFN-γ Ab (clone HB170, ATCC). Three days later, activated cells were purified by Percoll (GE Healthcare) gradient centrifugation. Purified effector cells were i.v. injected into syngeneic BALB/c hosts (10-20 × 10 6 cells/mouse), and persisting Ag-specific Th memory cells were harvested 3-6 weeks posttransfer.
Induction and Analysis of Th2-Mediated Allergic Asthma. OVA-specific Th2-polarized effector cells (5 × 10 5 cells for AHR induction, 10-20 × 10 6 cells for Th2 memory cell isolation) were adoptively transferred into naive BALB/c mice. Four weeks later, OVA-specific Th2 memory cells were isolated and induced to express Foxp3 by TGF-β, ATRA, anti-IL-4 and anti-IFN-γ Abs, and rapamycin in the presence of anti-CD3 and anti-CD28 Abs. After 5 days of culture, Th2 memory-derived Tregs, containing more than 80% of Foxp3 + cells, were isolated and adoptively transferred to Th2 memory-bearing mice (7.0-7.5 × 10 5 cells/mouse). OVA-specific CD4 + CD25 + or naive CD4 + T cells were injected as controls. In some experiments, Th2 memory-derived Tregs were injected after two i.n. challenges. Twenty-four hours after the Treg transfer, the mice were intranasally challenged with 50 μg OVA (grade VII, Sigma) four to five times as described in Fig. S9 A and D. AHR, BALF, and IgE levels in sera were assessed as previously described (47) . In some experiments, eosinophils in BALF were determined as SSC 
